{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-21-062398","form_type":"8-K","ticker":"KTTA","cik":"0001841330","company_name":"Pasithea Therapeutics Corp.","filed_at":"2021-11-29T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.636769+00:00","generated_at":"2026-06-28T05:11:22.840642+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Pasithea Therapeutics prices $30.4M private placement of 8.68M shares and warrants at $3.50/unit.","bullets":["Gross proceeds $30.4M from sale of 8.68M shares and accompanying warrants at $3.50 per unit.","Warrants immediately exercisable at $3.50, expire in 5 yrs; cashless exercise and ownership limits apply.","EF Hutton receives 9% cash fee plus 1% non-accountable expense fee and up to $70K accountable expenses.","Proceeds to fund pre-clinical R&D, US/UK clinic businesses, and working capital; resale registration due within 15 days."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-21-062398","json":"https://secwatch.observer/filing/0001213900-21-062398.json","markdown":"https://secwatch.observer/filing/0001213900-21-062398.md","text":"https://secwatch.observer/filing/0001213900-21-062398.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841330/000121390021062398/0001213900-21-062398-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841330/000121390021062398/ea151423-8k_pasithea.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T05:11:22.840642+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}